• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Sci Rep . Rare host variants in ciliary expressed genes contribute to COVID-19 severity in Bulgarian patients

tetano

Editor, Senior Moderator
Sci Rep


. 2024 Aug 22;14(1):19487.
doi: 10.1038/s41598-024-70514-3. Rare host variants in ciliary expressed genes contribute to COVID-19 severity in Bulgarian patients

Kunka Kamenarova[SUP] 1 2 [/SUP], Darina Kachakova-Yordanova[SUP] 3 4 [/SUP], Magdalena Baymakova[SUP] 5 [/SUP], Martin Georgiev[SUP] 3 4 [/SUP], Kalina Mihova[SUP] 3 4 [/SUP], Veronika Petkova[SUP] 3 4 [/SUP], Olga Beltcheva[SUP] 3 4 [/SUP], Radka Argirova[SUP] 6 [/SUP], Petar Atanasov[SUP] 7 [/SUP], Metodi Kunchev[SUP] 8 [/SUP], Radina Andonova[SUP] 5 [/SUP], Anelia Zasheva[SUP] 5 [/SUP], Rumiana Drenska[SUP] 7 [/SUP], Ivaylo Ivanov[SUP] 7 [/SUP], Diana Pantileeva[SUP] 7 [/SUP], Vesselina Koleva[SUP] 6 [/SUP], Anton Penev[SUP] 6 [/SUP], Diana Lekova-Nikova[SUP] 6 [/SUP], Delyan Georgiev[SUP] 3 4 [/SUP], Daniela Pencheva[SUP] 3 4 [/SUP], Radosveta Bozhilova[SUP] 3 4 [/SUP], Nevyana Ivanova[SUP] 3 4 [/SUP], Ivanka Dimova[SUP] 4 [/SUP], Kamen Plochev[SUP] 5 [/SUP], Georgi Popov[SUP] 5 [/SUP], Ivan Popivanov[SUP] 9 [/SUP], Nikolay Gabrovsky[SUP] 7 [/SUP], Magdalena Leseva[SUP] 7 [/SUP], Vanio Mitev[SUP] 3 [/SUP], Radka Kaneva[SUP] 3 4 [/SUP]



Affiliations
Abstract

Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) causes coronavirus disease 2019 (COVID-19), a pneumonia with extremely heterogeneous clinical presentation, ranging from asymptomatic to severely ill patients. Previous studies have reported links between the presence of host genetic variants and the outcome of the COVID-19 infection. In our study, we used whole exome sequencing in a cohort of 444 SARS-CoV-2 patients, admitted to hospital in the period October-2020-April-2022, to search for associations between rare pathogenic/potentially pathogenic variants and COVID-19 progression. We used gene prioritization-based analysis in genes that have been reported by host genetic studies. Although we did not identify correlation between the presence of rare pathogenic variants and COVID-19 outcome, in critically ill patients we detected known mutations in a number of genes associated with severe disease related to cardiovascular disease, primary ciliary dyskinesia, cystic fibrosis, DNA damage repair response, coagulation, primary immune disorder, hemoglobin subunit β, and others. Additionally, we report 93 novel pathogenic variants found in severely infected patients who required intubation or died. A network analysis showed main component, consisting of 13 highly interconnected genes related to epithelial cilium. In conclusion, we have detected rare pathogenic host variants that may have influenced the COVID-19 outcome in Bulgarian patients.

Keywords: COVID-19 severity and outcome; Cilia dysfunction; Host genetic variants; Rare protein-coding variants; SARS-CoV-2; WES.

 
Back
Top Bottom